Document is current
Any future updates will be listed below
-
Authors
Pasquini, Jacopo http://orcid.org/0000-0003-1856-2995
Maremmani, Carlo http://orcid.org/0000-0001-8229-2358
Salvadori, Stefano http://orcid.org/0000-0002-1266-3931
Silani, Vincenzo http://orcid.org/0000-0002-7698-3854
Ticozzi, Nicola
- License Information
-
More Information
Article History
Received: 8 November 2020
Accepted: 17 March 2021
First Online: 26 March 2021
Declarations
:
: The protocol (23C022) was approved by the Ethics Committee of Istituto Auxologico Italiano.
: Due to the exceptional emergency situation, informed consent was obtained verbally and recorded by the clinician who conducted the olfactory test (J.P., N.T.). The study conforms with World Medical Association Declaration of Helsinki.
: JP, SS, and NT have no relevant financial or non-financial interests to disclose.CM is the owner of the patent of the Italian Olfactory Identification Test (IOIT) (N.0001383361, issued by the Italian Ministry of Economic Development). The patent has not been licensed to third parties and the author has not received royalties linked to this patent.VS is in the Editorial Board of <i>Amyotrophic Lateral Sclerosis</i>, <i>European Neurology</i>, <i>American Journal of Neurodegenerative Diseases</i>, and <i>Frontiers in Neurology</i>; received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, and Zambon; and receives or has received research supports from the Italian Ministry of Health (Grant RF-201302355764), Fondazione Italiana di Ricerca per la SLA—AriSLA (Grant Exomefals and Novals), Fondazione Regionale per la Ricerca Biomedica Regione Lombardia (Project no. 2015-0023), and E-RARE JTC (Project Repetomics).
